This is a preview of subscription content, log in via an institution to check access.
Reference
Zhou N, et al. Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma. Frontiers in Pharmacology 14: Oct 2023. Available from: URL: https://dx.doi.org/10.3389/fphar.2023.1190967
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1988, 27 (2023). https://doi.org/10.1007/s40278-023-52005-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-52005-z